Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • jmRNA
    Junior Member
    • Apr 2012
    • 3

    #1

    % rRNA remaining after polyA selection

    Does anyone have a standard or threshold of % rRNA they require in order to proceed with mRNA library prep?

    In the past I've only proceeded with Illumina library prep after SeraMag polyA selection if I see 2% or less rRNA contamination on the bioanalyzer mRNA pico trace.

    I'm currently using the Dynabeads polyA kit to obtain mRNA for ScriptSeq library prep. I've been getting anywhere from 0-7% rRNA with the same protocol (all samples had high RINs). I'm wondering if the 2% threshold is too stringent.
  • mikaelk
    Member
    • Jun 2012
    • 11

    #2
    No I don't.
    It depends a lot on your sequencing requirements.
    If you do need a lot of coverage (so reads) on mRNA, keep the lowest thershold that you can.
    If having a high coverage on transcripts is not of prime interest to you you ca be lazy on your threshold.
    Without more information on what are your needs in terms of sequencing results, it is hard to say.

    Comment

    • pmiguel
      Senior Member
      • Aug 2008
      • 2328

      #3
      I think the %rRNA figure is going to be meaningless, or next to it, after polyA+ selection. This is because you will probably degrade your RNA a little during polyA+ selection, so any retained rRNA will no longer necessarily migrate where the bioanalyzer can recognize it as rRNA. If you want an accurate method, try qPCR.

      Anything below 10% rRNA in your final sequence is probably going to be good enough. Actually up to even 50% is still usable. It is a waste of sequence reads, but the non-rRNA should still map, etc.

      --
      Phillip

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 11:13 AM
      0 responses
      16 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, Yesterday, 10:48 AM
      0 responses
      17 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      35 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Working...